British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
All posts tagged in corporate mergers
2Articles
British companies are putting their flotation and merger plans on hold amid growing market uncertainty following last month’s budget announcement, according to leading broker Peel Hunt. The company, which serves
